Bone Marrow Concentrate Injection for Cartilage Defects

Procedure: During a BMC injection procedure, a small amount of bone marrow is extracted from the patient's hip or another suitable site. The bone marrow contains various cell types, including mesenchymal stem cells (MSCs) and growth factors that play a role in tissue repair and regeneration. The bone marrow sample is processed to concentrate the desired cell population, primarily MSCs, which have the potential to differentiate into different cell types, including cartilage cells (chondrocytes). The concentrated BMC is then injected directly into the site of the cartilage defect.

Mechanism of Action: The injected BMC contains MSCs that have the ability to differentiate into chondrocytes, the cells responsible for cartilage formation. These chondrocytes can help repair and regenerate damaged cartilage tissue. Additionally, MSCs can release various growth factors and cytokines that promote tissue healing, reduce inflammation, and stimulate the body's natural repair mechanisms.

Potential Benefits: BMC injection for cartilage defects offers several potential benefits:
Cartilage Regeneration: The presence of MSCs and growth factors in the injected BMC may help stimulate the growth of new cartilage tissue, leading to the repair of cartilage defects.
Reduced Inflammation: The anti-inflammatory properties of MSCs can help reduce inflammation at the site of the cartilage defect, creating a favorable environment for healing.
Minimal Invasiveness: BMC injection is a minimally invasive procedure that can be performed in an outpatient setting. It avoids the need for major surgery and reduces associated risks.
Autologous Treatment: Using the patient's own bone marrow reduces the risk of immune rejection or adverse reactions.